Polar Capital Holdings Plc

Position in ASND — Ascendis Pharma A/S

CIK 1837309 London, X0

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$149,066,085

+$70,066,423 QoQ

Shares Held

651,712

+75.9% QoQ

Ownership

0.994%

of shares outstanding

% of Portfolio

0.68%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Polar Capital Holdings Plc holds $3,129,351,296 across 43 Biotechnology names. ASND ranks #6 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	XENE	Xenon Pharmaceuticals Inc.	4,405,312	$256,168,892
2	ELVN	Enliven Therapeutics, Inc.	5,065,933	$198,584,573
3	NUVL	Nuvalent, Inc.	1,831,253	$187,611,869
4	BBIO	BridgeBio Pharma, Inc.	2,519,306	$187,083,663
5	MDGL	Madrigal Pharmaceuticals, Inc.	289,310	$151,445,105
6	ASND	Ascendis Pharma A/S This page	651,712	$149,066,085
7	REGN	Regeneron Pharmaceuticals, Inc.	192,546	$148,768,741
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,615,586	$140,507,514

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$149,066,085	651,712	+75.9%	Shares	Defined	2026-05-15
2025-12-31	$78,999,662	370,473	-56.8%	Shares	Defined	2026-02-17
2025-09-30	$170,561,285	857,911	+2.4%	Shares	Defined	2025-11-14
2025-06-30	$144,600,310	837,777	+59.6%	Shares	Defined	2025-08-14
2025-03-31	$81,826,500	525,000	+75.0%	Shares	Defined	2025-05-15
2024-12-31	$41,301,000	300,000	+33.3%	Shares	Defined	2025-02-14
2024-09-30	$33,594,750	225,000	+8814.4%	Shares	Defined	2024-11-14
2021-03-31	$325,293	2,524	-95.2%	Shares	Sole	2021-05-17
2020-12-31	$8,759,952	52,524	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.